STTR Phase I: A Novel Biorational Approach to Curing Honey Bees

STTR 第一阶段:一种新的生物理性治疗蜜蜂方法

基本信息

  • 批准号:
    2152247
  • 负责人:
  • 金额:
    $ 27.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-10-01 至 2024-09-30
  • 项目状态:
    已结题

项目摘要

The broader impact of this Small Business Technology Transfer (STTR) Phase I project is to enhance honey bee health and hence crop production through the development of a biological treatment for Varroa destructor mite, the greatest single cause of honey bee decline. All honey bee colonies in the U.S. (2.5 million) are infested with parasitic Varroa destructor mites which cause devastating colony loss due to the impact of the mite itself as well as the transfer of microbial diseases it carries. Currently, both commercial and hobbyist beekeepers must decide between losing a colony now to Varroa destructor infestation, or later to consequent pesticide effects. Bringing a safe and effective new biological-based product to the market will lower beekeeper’s annual spending as well as time and effort to keep their colonies alive by leaving honey bee colonies free from the devastating downstream effects of traditional pesticides. In addition, the solution paves the way for more biologicals to be developed and commercialized through the novel scientific approach and technological advancement proposed herein, essentially reducing the perceived risk. The proposed project seeks to bring to market a novel, biorational, scientific approach in pesticide management of Varroa destructor mite infestation. This biorational pesticide is designed to target a little bug (the mite) that lives on a big bug (the honey bee) without harming the bee. No pesticide has previously taken the biorational approach described herein, thus a variety of experiments are necessary to optimize manufacturing and administration methods as well as provide proof of concept prior to bringing this product to market. The specific aims include: 1) the development of efficient and cost-effective mass production methods through empirical testing of varying growth conditions, 2) testing of various administration methods, including, but not limited to, liquid- and powder-based methods that are scalable and end-user friendly for three different groups of beekeepers (commercial, sideline, and hobbyist honey beekeepers), and 3) additional mode of action experiments to solidify the “proof of concept” of the novel technological advancement, including an in-depth examination of the effect on honey bee heath. This technology will include developing administration methods suitable for warehouses containing hundreds of colonies.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该小企业技术转让 (STTR) 第一阶段项目的更广泛影响是通过开发针对瓦螨的生物处理方法来增强蜜蜂的健康,从而提高作物产量,瓦螨是蜜蜂数量下降的最大单一原因。在美国(250 万),有寄生瓦螨感染,由于螨本身的影响及其携带的微生物疾病的传播,造成毁灭性的群体损失。商业养蜂人和业余养蜂人都必须做出决定,是现在因瓦螨侵扰而失去蜂群,还是随后因农药的影响而失去蜂群,将安全有效的新型生物基产品推向市场将降低养蜂人的年度支出以及养蜂的时间和精力。通过使蜜蜂群体免受传统农药的破坏性下游影响,使他们的群体保持活力。此外,该解决方案为通过本文提出的新颖的科学方法和技术进步开发和商业化更多生物制品铺平了道路。该项目旨在从根本上降低感知风险,将一种新颖的、生物合理的科学方法推向市场,用于防治瓦螨侵扰。这种生物合理的农药旨在针对以大虫为生的小虫(螨)。以前没有农药采用本文所述的生物合理方法,因此需要进行各种实验来优化制造和施用方法,并在将该产品推向市场之前提供概念证明。目标包括:1) 通过对不同生长条件的实证测试,开发高效且具有成本效益的大规模生产方法,2) 测试各种给药方法,包括但不限于可扩展和可扩展的基于液体和粉末的方法。对三类不同的养蜂人(商业养蜂人、副业养蜂人和业余养蜂人)而言,最终用户友好,以及3)额外的行动实验模式,以巩固新颖技术进步的“概念验证”,包括深入研究效果该技术将包括开发适合包含数百个蜂群的仓库的管理方法。该奖项反映了 NSF 的法定使命,并通过使用基金会的智力价值和更广泛的影响审查标准进行评估,被认为值得支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Lewis其他文献

Acceleration of Coronal Mass Ejection Plasma in the Low Corona as Measured by the Citizen CATE Experiment
通过 Citizen CATE 实验测量低日冕中日冕物质抛射等离子体的加速
  • DOI:
    10.1088/1538-3873/ab558c
  • 发表时间:
    2019-12-12
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    M. Penn;R. Baer;D. Walter;M. Pierce;R. Gelderman;A. Ursache;D. Elmore;A. Mitchell;S. Kovac;H. Hare;M. Mckay;L. Jensen;Z. Watson;M. Conley;L. Powers;M. Lazarova;Joseph Wright;D. Young;F. Isberner;C. A. Hart;N. Sheeley;Debbie Penn;Kate Allen;B. Alder;R. Alder;Geri Hall;D. Gerdes;Katherine Weber;Jeff Johnson;Gerald Matzek;S. Somes;Rob Sobnosky;R. McGowen;M. Meo;D. Proctor;Charlie Wessinger;J. Schilling;J. Kerr;A. Beltzer;Alex Falatoun;D. Higgins;G. Boyce;Jared Hettick;Philip R Blanco;Scott Dixon;Sepehr Ardebilianfard;P. Boyce;R. Lighthill;D. Lighthill;David Anderson;M. Anderson;T. Schad;Sonna Smith;Declan Jensen;A. Allen;D. Smith;G. Br;on;on;J. Earp;J. Earp;Bob Blair;C. Claver;J. Claver;Ryan H. Claver;Daniel S. Hoops;E. Rivera;Llanee Gibson;M. Hiner;Rein Lann;Shaedyn Miller;B. Briggs;Karan Davis;B. Jackson;Kaleb Kautzsch;Wesley S;idge;idge;Russell Lucas;D. Gregg;J. Kamenetzky;T. Rivera;J. Shaw;Bryan Scherrer;Dylan S;bak;bak;R. McFate;W. Harris;Zachery Brasier;S. McNeil;Jack Jensen;M. Jensen;M. Moore;A. Temple;T. V;erhorst;erhorst;R. Kautz;Orion Bellorado;LaVor R Jenkins;Corey N Pantuso;M. Carey;J. Byrnes;Kyle Scholtens;J. Web;Brain Baker;Katie Barngrover;D. Hathaway;Kallen Smith;Kelly Ch;ler;ler;L. Hinkle;Ione Ch;ler;ler;G. Gisler;J. Benner;M. Mas;M. Rogers;P. Moore;Elijah Pelofske;S. Gulley;B. Short;Isabel Crooker;J. Hammock;Katsina Cardenas;Kateri Cardenas;J. Wellman;M. Roy;Joe Meyer;J. Brough;K. Brough;Tim Nelson;Zack Nelson;C. Russell;T. Bautz;Eric Weitzel Team;Michele Wistisen;Shae Aagard;Zachary Whipps;Logan Neuroth;D. Poste;C. Worthen;S. Gosain;M. Steward;V. Gosain;R. Gosain;J. Jorgensen;E. Doucette;R. Doucette;Elliott Iwen;A. Cochran;J. Stith;Doug Scribner;A. Kenney;Kolby Pisciotti;Irene Pease;Samuel Cynamon;C. Cynamon;Dawn Cynamon;B. Tolbert;J. Dupree;J. M. Weremeichik;Nathan Pindell;Kristen Stives;T. Simacek;Yolanta G Simacek;Anne L. Simacek;W. Boeck;A. Boeck;Austin T Ryan;Gabriel Wierzorec;D. Klebe;B. Costanza;Arnie Cerny;Trevor Schmale;T. Hoffman;S. Streeter;J. Erickson;M. McClellan;Ella Erickson;B. Brettell;Savannah Shoffner;Emilie McClellan;Julie VanVoorhis;Cole Bramhall;Daniel Stelly;Bentley Bee;B. Acevedo;M. Kroeger;Ben Trumpenski;Nolan Sump;L. Brook;J. Ernzen;Jessica Lewis;R. Maderak;Charles Kennedy;David Dembinski;Rita Wright;Michael Foster;Mohammad Ahmadbasir;Monty Laycox;Jennifer Foster;E. Orr;Ashley Staab;A. Speck;S. Baldridge;L. Kegley;Jordan Bavlnka;Thomas J. Ballew;B. Callen;G. Ojakangas;Mark Bremer;Maryanne Angliongto;M. Redecker;C. Bremer;Peggy P. Hill;M. Rodgers;Jordan Duncan;Samuel M. E. Fincher;B. Nielsen;S. Hasler;Taylor Shivelbine;T. Howard;C. Midden;S. Patrick;Kerry Glenn;Christopher M;rell;rell;Kyle S. Dawson;M. Cortez;Alyssa Levsky;Dinuka H. Gallaba;M. Perrone;Jasmyn Taylor;P. Yanam;ra;ra;H. Harper;Lindsay Adams;Michael J. Springer;Bill Menard;D. Boggs;Caitlin G. Lynch;J. Watson;A. York;D. Matthews;Kiley Brown;D. Garrison;Jonathan Mangin;I. Mangin;J. Birriel;I. Birriel;C. Yess;Jesse C. Anderson;Ethan Caudill;A. Smith;S. Buckner;Russ Longhurst;Ben Fagan;C. Nations;Jeffrey DiMatties;P. Thompson;D. Garrison;Thomas Garrison;William Garrison;Mary Kidd;M. Baker;Mary;A. Winebarger;M. Freed;M. Church;J. Dickens;Bob Anderson;Ned M. Smith;L. Dorsey;Douglas Justice;Daniel Zavala;Zach Stockbridge;S. Brittain;S. Jensen;H. Leiendecker;Erin Thompson;M. Deady;Kelly D. Quinn;D. Slimmer;V. Granger;M. LaRoche;S. Laroche;Rachel Manspeaker;Peter Nguyen;Daniel M. Smith;Jim Payne;Jerry Zissett;A. Roberts;Gabrielle Roberts;H. Roberts;A. Riddle;C. Ursache;E. Ursache
  • 通讯作者:
    E. Ursache
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
BNT162b2 和 mRNA-1273 COVID-19 疫苗的安全性、免疫原性和反应原性,在两剂 ChAdOx1 nCoV-19 或 BNT162b2 和第三剂 BNT162b2 (COV-BOOST) 后作为第四剂加强剂给予:多中心、盲法阶段
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Munro;S. Feng;L. Janani;V. Cornelius;P. Aley;G. Babbage;D. Baxter;M. Bula;K. Cathie;Krishna Chatterjee;Kate Dodd;Y. Enever;Ehsaan Qureshi;A. Goodman;C. Green;L. Harndahl;J. Haughney;A. Hicks;A. A. van der Klaauw;Nasir Kanji;V. Libri;M. Llewelyn;A. McGregor;Mina H. Maallah;A. Minassian;P. Moore;M. Mughal;Y. Mujadidi;K. Holliday;O. Osanlou;R. Osanlou;Daniel R Owens;Mihaela Pacurar;A. Palfreeman;D. Pan;T. Rampling;K. Regan;Stephen Saich;Tanveer Bawa;D. Saralaya;S. Sharma;R. Sheridan;E. Thomson;Shirley Todd;C. Twelves;R. Read;S. Charlton;B. Hallis;M. Ramsay;N. Andrews;T. Lambe;J. Nguyen;M. Snape;Xinxue Liu;S. Faust;A. Riordan;A. Ustianowski;Chris A Rogers;K. Katechia;A. Cooper;Andrew Freedman;Rachel Hughes;L. Grundy;Lona Tudor Jones;Elizabeth Harrison;E. Snashall;L. Mallon;Katharine Burton;K. Storton;Malathi Munusamy;B. Tandy;Akamino Egbo;S. Cox;N. Ahmed;Anil Shenoy;R. Bousfield;D. Wixted;H. Gutteridge;B. Mansfield;Christopher Herbert;J. Murira;J. Calderwood;D. Barker;J. Brandon;H. Tulloch;Suzie Colquhoun;H. Thorp;H. Radford;Julie Evans;H. Baker;J. Thorpe;S. Batham;J. Hailstone;R. Phillips;Dileep Kumar;F. Westwell;A. Sturdy;Lara Barcella;N. Soussi;Mushiya Mpelembue;S. Raj;Rajni Sharma;T. Corrah;L. John;A. Whittington;S. Roche;L. Wagstaff;A. Farrier;K. Bisnauthsing;Movin Abeywickrama;N. Spence;A. Packham;T. Serafimova;Suahil Aslam;Caitlin McGreevy;A. Borca;Pamela DeLosSantosDominguez;Emily Palmer;S. Broadhead;S. Farooqi;Joshua M. Piper;Rowena Weighell;L. Pickup;Djamila Shamtally;Jason Domingo;Evgenia Kourampa;C. Hale;J. Gibney;Michael Stackpoole;Zalina Rashid;R. Lyon;Chloe McDonnell;C. Cole;A. Stewart;G. Mcmillan;Mary Savage;H. Beckett;Chantelle Moorbey;A. Desai;Claire Brown;Kush Naker;Karishma Gokani;Charlotte Trinham;Charlette Sabine;Sophie Moore;Steve Hurdover;E. Justice;M. Stone;Emma L Plested;Carla Ferreira da Silva;Rachel White;H. Robinson;I. Turnbull;Gertraud Morshead;R. Drake;C. Smith;Grace Li;Mwila Kasanyinga;E. Clutterbuck;S. Bibi;Michael Singh;Trishna Champaneri;Margaret Irwin;Mohammed Khan;Alicia Kownacka;Martha Nabunjo;Carol Osuji;John Hladkiwskyj;D. Galvin;Gitaben K Patel;J. Grierson;Samantha Males;Krishna Askoolam;Joshua Barry;J. Mouland;B. Longhurst;M. Moon;Beth Giddins;C. Pereira Dias Alves;L. Richmond;C. Minnis;S. Baryschpolec;S. Elliott;L. Fox;Victoria A. Graham;Natalie Baker;K. Godwin;K. Buttigieg;Chanice Knight;Phillip J. Brown;Paminder Lall;Imam H. Shaik;Emily Chiplin;Emily Brunt;Stephanie Leung;Lauren Allen;Steve Thomas;Sara Fraser;Bea Choi;Jade Gouriet;J. Perkins;Andrew Gowland;J. Macdonald;J. Seenan;Igor Starinskij;A. Seaton;E. Peters;S. Singh;Ben Gardside;Avril Bonnaud;Ceri Davies;Elizabeth Gordon;S. Keenan;Jane Hall;S. Wilkins;S. Tasker;R. James;Ingrid Seath;Kelly Littlewood;J. Newman;Iryna Boubriak;Debbie Suggitt;Helen Haydock;S. Bennett;W. Woodyatt;K. Hughes;Judith Bell;Tricia Coughlan;Donald van Welsenes;M. Kamal;Chris Cooper;Simon Tunstall;Nicholas Ronan;R. Cutts;T. Dare;Y. T. N. Yim;Sarah Whittley;Shama Hamal;Marivic Ricamara;Kirsty Adams;Holly Baker;Kimberley Driver;N. Turner;T. Rawlins;Subarna Roy;Marta Merida;Yukari Sakagami;Antonette Andrews;Lillian Goncalvescordeiro;Matthew Stokes;W. Ambihapathy;Joanne Spencer;Nina Parungao;L. Berry;James Cullinane;L. Presland;Amy L Ross Russell;Sarah C. Warren;Jonathan Baker;A. Oliver;A. Buadi;Kim Lee;L. Haskell;R. Romani;I. Bentley;Tim Whitbred;S. Fowler;John T. Gavin;A. Magee;Tara Watson;Kari Nightingale;P. Marius;Eloise Summerton;Emily Locke;ThomasJack Honey;Aidan Lingwood;Anastasia de la Haye;R. S. Elliott;Karen Underwood;M. King;Sharon Davies;E. Horsfall;Olivia Chalwin;H. Burton;C. Edwards;B. Welham;Kim Appleby;Emily Dineen;Sarah Garrahy;F. Hall;Eleni Ladikou;D. Mullan;D. Hansen;Marion Campbell;Filipa Dos Santos;N. Lakeman;D. Branney;L. Vamplew;A. Hogan;J. Frankham;M. Wiselka;D. Vail;V. Wenn;V. Renals;K. Ellis;Jessica Lewis;H. Habash;J. Magan;Anna C. Hardy
  • 通讯作者:
    Anna C. Hardy
The Relationship between Parent-reported PEDI-CAT Mobility and Gross Motor Function in Children with Cerebral Palsy: Brief Report
家长报告的脑瘫儿童 PEDI-CAT 活动能力与粗大运动功能之间的关系:简要报告
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    1.3
  • 作者:
    Jessica Lewis;Kimberley Scott;X. Pan;J. Heathcock
  • 通讯作者:
    J. Heathcock
Broiler Litter Ash and Flue Gas Desulfurization Gypsum Effects on Peanut Yield and Uptake of Nutrients
肉鸡垫灰和烟气脱硫石膏对花生产量和养分吸收的影响
Utilization of the Maryland Environmental Justice Screening Tool: A Bladensburg, Maryland Case Study
马里兰州环境正义筛选工具的利用:马里兰州布莱登斯堡案例研究

Jessica Lewis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

热带河口特有鱼类尖鳍鲤早期生活史不同阶段的栖息地利用变化及驱动机制
  • 批准号:
    32360917
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于现代监测的湘西惹迷洞MIS2阶段石笋碳同位素和微量元素记录重建研究
  • 批准号:
    42371164
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
高层钢结构建模-优化-深化的跨阶段智能设计方法
  • 批准号:
    52308142
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
马尾松和粘盖乳牛肝菌预共生阶段互作机制研究
  • 批准号:
    32360372
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
低碳环境下考虑阶段间运输混合流水车间成组调度的协同智能优化方法
  • 批准号:
    72301026
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

STTR Phase I: Innovating Micro-Light Emitting Diode (LED) Manufacturing with Novel Quantum Dot Micro-Patterning Technology
STTR 第一阶段:利用新型量子点微图案化技术创新微发光二极管 (LED) 制造
  • 批准号:
    2335283
  • 财政年份:
    2024
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Standard Grant
STTR Phase I: A novel wall-mounted gait assist system to reduce the risk of injuries on stairs and level surfaces
STTR 第一阶段:一种新型壁挂式步态辅助系统,可降低楼梯和水平面上受伤的风险
  • 批准号:
    2304063
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Standard Grant
STTR Phase I: Advancing DNA Testing with a Novel Platform for Processing Touch Biological Evidence
STTR 第一阶段:利用处理触摸生物证据的新型平台推进 DNA 检测
  • 批准号:
    2243209
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Standard Grant
STTR Phase I: Novel Medical Equipment Utilization Tracking System for Improved Patient Safety and Hospital Efficiency
STTR 第一阶段:新型医疗设备使用跟踪系统,以提高患者安全和医院效率
  • 批准号:
    2321886
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Standard Grant
STTR Phase I: A Novel Prescription Process that Customizes Prosthetic Feet for Individual Patients
STTR 第一阶段:为个体患者定制假足的新颖处方流程
  • 批准号:
    2233114
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了